Patients who use Prevacid may be at risk for serious kidney complications, including renal failure, nephritis and chronic kidney disease. Those who were diagnosed with any of these health problems could be entitled to compensation if it is determined that the manufacturers of Prevacid and other proton pump inhibitors failed to provide patients with adequate warnings about these risks.
Bernstein Liebhard LLP is now investigating Prevacid kidney failure claims, and our attorneys are offering free legal reviews to anyone who may have been harmed by this heartburn medication. To learn more, please call .
Prevacid (lansoprazole) is a proton-pump inhibitor (PPI) that is used to treat heartburn and symptoms associated with GERD. The medication is available via prescription, and it is also sold over-the-courter as Prevacid24. According to a study published in JAMA: Internal Medicine in January 2016, about 23 million Americans were prescribed a proton pump inhibitor in 2013. However, as many as 70% of those scripts may be inappropriate. In fact, the authors of the study asserted that a quarter of long-term users could stop taking their proton pump inhibitor without suffering increased heartburn.
The use of Prevacid and other proton pump inhibitors has already been linked to short-term kidney problems, including acute kidney injury and acute interstitial nephritis. However, new research also indicates that these drugs may be associated with an increased risk of chronic kidney disease and renal failure.
Acute interstitial nephritis is a reversible inflammation of the kidneys. A number of case reports published over the past decade have linked Prevacid and other proton inhibitors to the onset of the condition. However, warnings about nephritis were not added to the drugs’ labels until 2014.
While nephritis is reversible, the disorder can result in kidney failure if the condition is not recognized and treated quickly. In fact, it is estimated that about 1-3% of all cases of kidney failure are caused by nephritis.
People who use Prevacid and other proton pump inhibitors may be 96% more likely to develop kidney failure and 26% more likely to develop kidney disease compared to patients who used another class of heat burn drugs called H2 blockers, according to research recently published in the Journal of the American Society of Nephrology. The authors of the April 2016 study tracked 200,000 U.S. veterans for five years, and found that kidney failure occurred 3X more often among people who used proton pump inhibitors for 1-2 years compared to those who took the drugs for a month or less. Though renal failure was only reported in 0.2% of people in the study, it was nearly twice as common in those who used drugs like Prevacid.
The April 2016 study also found that 15% of the patients taking proton pump inhibitors developed chronic kidney disease vs. only 11% of those who took H2 blockers like Zantac. Just four months earlier, research published in JAMA: Internal Medicine suggested that twice-daily use of Prevacid and other proton pump inhibitors increased the risk for chronic kidney disease by 46%. Daily use of a proton pump inhibitor was associated with a 15% increased risk. Read More
If you or someone you care about were diagnosed with kidney disease or renal failure following long-term use of Prevacid, it is important that you contact an attorney to ensure your legal rights are protected. To learn more about filing a Prevacid lawsuit, please call Bernstein Liebhard LLP at .